Dr. Manivannan Elangovan
My Social Links

Dr. Manivannan Elangovan

Assistant Professor
Devi Ahilya Vishwavidyalaya, India


Highest Degree
Ph.D. in Bioorganic Chemistry from Devi Ahilya Vishwa Vidyalaya, Indore, India

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Pharmacology
62%
Drug Discovery
90%
Inflammation
75%
Immunopharmacology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
39
Abstracts
4

Selected Publications

  1. Manivannan, E. and S.C. Chaturvedi, 2010. Design and synthesis of 2, 3-diaryl quinazolin-4- ones for cyclooxgenase-2 inhibition. Eur. Med. Chem. .
  2. Manivannan, E. and S.C. Chaturvedi, 2009. QSAR investigations on benzylideneamino and phenyliminomethyl scaffolds for selective COX-2 inhibition: A hansch approach. Med. Chem., 5: 440-445.
    CrossRef  |  Direct Link  |  
  3. Manivannan, E. and S.C. Chaturvedi, 2009. QSAR analysis of centrally fused 1,5 diaryl pyrazoles for cyclooxygenase inhibition using MOE-Qua-SAR descriptors. Med. Chem. Res., 18: 396-405.
    CrossRef  |  Direct Link  |  
  4. Prasanna, S., E. Manivannan and S.C. Chaturvedi, 2005. Quantitative structure-activity relationship studies of cyclooxygenase inhibitors: A comprehensive analysis. Drug Dev. Res., 64: 220-231.
    CrossRef  |  Direct Link  |  
  5. Prasanna, S., E. Manivannan and S.C. Chaturvedi, 2005. Quantitative structure-activity relationship analysis of 2,3 diaryl indoles as selective cyclooxygenase-2 inhibitors. J. Enz. Inhibit. Med. Chem., 20: 455-461.
    CrossRef  |  Direct Link  |  
  6. Prasanna, S., E. Manivannan and S.C. Chaturvedi, 2005. QSAR studies on structurally similar 2-(4-methanesulfonylphenyl) pyran-4-ones as selective COX-2 inhibitors: A hansch approach. Bioorg. Med. Chem. Lett., 15: 313-320.
    CrossRef  |  Direct Link  |  
  7. Prasanna, S., E. Manivannan and S.C. Chaturvedi, 2005. QSAR analysis of conformationally restricted 1,5-diaryl pyrazoles as selective COX-2 inhibitors: Application of connection table representation of ligands. Bioorg. Med. Chem. Lett., 15: 2097-2102.
    CrossRef  |  Direct Link  |  
  8. Manivannan, E. and S. Prasanna, 2005. First QSAR report on FSH receptor antagonistic activity: Quantitative investigations on physico-chemical and structural features among 6-amino-4-phenyl tetrahydroquinoline derivatives. Bioorg. Med. Chem. Lett., 15: 4496-4501.
    CrossRef  |  
  9. Prasanna, S., E. Manivannan and S.C. Chaturvedi, 2004. Quantitative structure-activity relationship analysis of a series of 2,3 diaryl benzopyran analogues as novel selective cyclooxygenase-2 inhibitors. Bioorg. Med. Chem. Lett., 14: 4005-4011.
    CrossRef  |  
  10. Prasanna, S., E. Manivannan and S.C. Chaturvedi, 2004. QSAR analysis of some fused pyrazoles as selective Cyclooxygenase-2 inhibitors: A hansch approach. Arch. Der. Pharm., 337: 440-444.
    CrossRef  |  
  11. Prasanna, S., E. Manivannan and S.C. Chaturvedi, 2004. QSAR analysis of 2,3 diaryl benzopyrans/pyrans as selective COX-2 inhibitors based on semiempirical AM1 calculations. QSAR Comb. Sci., 23: 621-621.
    CrossRef  |  Direct Link  |  
  12. Manivannan, E., S. Prasanna and S.C. Chaturvedi, 2004. Rationalization of physicochemical properties of 5,6-diarylthiazolo[3,2-b]-1,2,4-triazoles towards cyclooxygenase-2 inhibition: A QSAR approach. Indian J. Biochem. Biophys., 41: 179-183.